Publications

Journal Article Epublish 2 citations
Open access — free full text available
Open access
Electronic publication date
November 25, 2023

View on Pubmed.gov 38005995 | View on doi.org 10.3390/vaccine... | View the free full text Full text

Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.

Search for publications in this journal Vaccines (Basel)

Abstract

Despite the important role of gut microbiota in the maturation of the immune system, little is known about its impact on the development of T-cell responses to vaccination. Here, we immunized C57BL/6 mice with a prime-boost regimen using DNA plasmid, the Chimpanzee Adenovirus, and the modified Vaccinia Ankara virus expressing a candidate HIV T-cell immunogen and compared the T-cell responses between individuals with an intact or antibiotic-depleted microbiota. Overall, the depletion of the gut microbiota did not result in significant differences in the magnitude or breadth of the immunogen-specific IFNγ T-cell response after vaccination. However, we observed marked changes in the serum levels of four cytokines after vaccinating microbiota-depleted animals, particularly a significant reduction in IL-22 levels. Interestingly, the level of IL-22 in serum correlated with the abundance of in the large intestine of mice in the mock and vaccinated groups with intact microbiota. This short-chain fatty acid (SCFA)-producing bacterium was significantly reduced in the vaccinated, microbiota-depleted group. Therefore, our results indicate that, although microbiota depletion reduces serum levels of IL-22, the powerful vaccine regime used could have overcome the impact of microbiota depletion on IFNγ-producing T-cell responses.

References

Mucosal Immunol. 2020 Mar;13(2):183-189

EBioMedicine. 2023 Feb;88:104430

Microbiome. 2020 Nov 23;8(1):167

Nat Med. 2016 Oct;22(10):1187-1191

Cited by 2 citations (total)

Journal Article Review

Prospects for therapeutic T-cell vaccine strategies for HIV cure.

Electronic publication date August 7, 2025

Search for publications in this journal Curr Opin HIV AIDS

Beatriz Mothe [...] Christian Brander et al.

PURPOSE OF REVIEW

This review article aims to summaries the advances in T-cell vaccination as a component of HIV cure strategies....

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties